Fexostad 120

OTC

Indications:

Relief of symptoms associated with seasonal allergic rhinitis and chronic idiopathic urticaria in adults and children ≥ 12 years old.

Dosage:

Adults and children aged 12 years and over: 120 mg (one tablet) once daily.

Usage:

Fexostad 120 is orally administered and taken before a meal.

• Patients with known hypersensitivity to fexofenadine hydrochloride or any ingredients of drug.
• Children under 12 years of age.

Common: Drowsiness, fatigue, headache, insomnia, dizziness. Nausea, indigestion. Virus infection (cold, flue), dysmenorrhea, upper respiratory tract infections, itchy throat, cough, fever, tympanitis, sinusitis, backache.

Uncommon: Dry mouth, stomachache. Fear, sleep disorders, nightmare.

• Monitoring renal function may be useful and dosage should be selected with caution in elderly patients.
• Fexofenadine has been associated with increased QTc interval, syncope, and ventricular arrhythmia in at least one susceptible patient with preexisting cardiovascular risk.
• Patients also should be advised not to use other antihistamines or decongestants for self-medication. If nervousness, dizziness, or sleepiness occurs during therapy, patients should be advised to discontinue use of the fixed-combination preparation and consult a clinician.
• Fexostad 120 should be used during pregnancy only when the potential benefits justify the possible risks to the fetus. Fexofenadine should be used with caution in nursing women, and a decision should be made whether to discontinue nursing or the drug.
• Patients should be aware of how they react to Fexostad 120 before driving or operating machinery.